AndrewDavidFesnakMD

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Clinical Pathology Resident Physician- PGY2

Dr. Fesnak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce St.
3 Ravdin Building
Philadelphia, PA 19104
Phone+1 215-662-3225

University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2011 - 2015
Rutgers Robert Wood Johnson Medical SchoolClass of 2011
University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine

PubMed

1 citations
Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis.
Ethan A Mack, Meaghan C Dougher, Ashley M Ginda, Caitlin Cahill, Melissa Murter
Blood. 2024-03-14
5 citations
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?
Indira Guleria, Maria de Los Angeles Muñiz, Matthew Wilgo, Asawari Bapat, Wanxing Cui
Transfusion. 2022-03-01
48 citations
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
Katharine J. Bar, Pamela A. Shaw, Grace H Choi, Nicole A. Aqui, Andrew D. Fesnak
The Journal of Clinical Investigation. 2021-11-17

Abstracts/Posters

Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
Andrew Fesnak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to El...
Andrew Fesnak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019